MoonLake Immunotherapeutics
MLTX
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Revenue | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Total Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenues | 1,487.00 | 0.00 | 13.16 | 0.00 | 0.00 | |
| Gross Profit | -1,487.00 | 0.00 | -13.16 | 0.00 | 0.00 | |
| Operating Income | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 31,801.88 | 42,048.95 | 0.00 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 22,321.22 | 23,012.46 | 4,570.35 | |
| Depreciation & Amortization | 3,166.29 | 1,384.73 | 13.16 | 12.36 | 0.00 | |
| Total Operating Expenses | 227,710.37 | 143,091.08 | 54,123.10 | 65,061.42 | 4,570.35 | |
| Operating Income | -229,197.37 | -143,091.08 | -54,123.10 | -65,061.42 | -4,570.35 | |
| Net Income | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 5,253.00 | 0.00 | 0.00 | -591.73 | 0.00 | |
| Other Expense | 15,901.81 | 22,128.88 | 10,138.37 | 591.73 | 27.69 | |
| IBT | -213,295.56 | -120,962.20 | -43,984.73 | -64,469.69 | -4,542.65 | |
| Income Tax Expense | 404.14 | 282.20 | 94.39 | 36.37 | 0.00 | |
| Net Income | -210,497.51 | -118,935.52 | -36,007.26 | -64,506.05 | -4,542.65 | |
| Per Share Data | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $-0.73 | $-2.20 | $-0.38 | |
| EPS Diluted | $0.00 | $0.00 | $-0.73 | $-2.20 | $-1.58 | |
| Shares Outstanding | 63,369.98 | 62,870.24 | 49,122.53 | 29,361.35 | 11,930.00 | |
| Diluted Shares Outstanding | 63,369.98 | 62,870.24 | 49,122.53 | 29,361.35 | 2,875.00 | |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 342,791.14 | 180,426.45 | 451,169.34 | 39,505.63 | 8,038.85 | 0.00 | |
| Short Term Investments | 177,008.40 | 267,600.90 | 59,838.90 | 32,609.11 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 519,799.54 | 448,027.35 | 511,008.24 | 72,114.74 | 8,038.85 | 0.00 | |
| Accounts Receivable | 1,676.81 | 2,843.20 | 1,056.86 | 217.13 | 148.77 | 0.00 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 1,322.18 | 0.00 | |
| Other Current Assets | 15,405.53 | 23,418.30 | 2,102.20 | 4,179.47 | 126.92 | 0.00 | |
| Total Current Assets | 536,881.88 | 474,288.85 | 514,167.30 | 76,511.33 | 9,636.72 | 0.00 | |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3,866.66 | 3,644.44 | 3,949.35 | 331.97 | 45.74 | 0.00 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 115,042.61 | 0.00 | |
| Other Long-Term Assets | 4,129.15 | 0.00 | 8,423.47 | 0.00 | -115,042.61 | 0.00 | |
| Total Long-Term Assets | 7,995.81 | 3,644.44 | 12,372.81 | 331.97 | 45.74 | 0.00 | |
| Total Assets | 544,877.69 | 477,933.28 | 526,540.12 | 76,843.30 | 9,682.45 | 0.00 | |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Accounts Payable | 55.99 | 8,678.41 | 0.00 | 254.97 | 1,428.45 | 0.00 | |
| Short-Term Debt | 1,321.73 | 1,371.96 | 1,306.13 | 153.63 | 15,000.00 | 0.00 | |
| Other Current Liabilities | 10,341.25 | 11,771.38 | 8,291.58 | 7,256.85 | 4,659.15 | 0.00 | |
| Current Liabilities | 12,281.96 | 22,463.86 | 9,965.68 | 7,665.45 | 21,087.60 | 0.00 | |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Long-Term Debt | 2,022.28 | 1,457.60 | 2,499.99 | 128.95 | 0.00 | 0.00 | |
| Capital Leases | 2,022.28 | 2,829.56 | 3,806.12 | 282.58 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 14,846.19 | 24,542.14 | 13,049.10 | 8,076.60 | 21,327.46 | 0.00 | |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Common Stock | 6.39 | 6.39 | 6.30 | 5.27 | 38.54 | 0.00 | |
| Retained Earnings | -154,598.14 | -235,592.99 | -116,657.47 | -80,650.21 | -53,643.62 | 0.00 | |
| Comprehensive Income | 3,256.91 | 4,996.77 | 2,357.62 | 350.95 | -168.18 | 0.00 | |
| Total Common Equity | 520,663.74 | 446,825.00 | 495,675.68 | 48,898.30 | -11,645.01 | 0.00 | |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Debt | 3,344.01 | 2,829.56 | 3,806.12 | 282.58 | 15,000.00 | 0.00 | |
| Book Value | 530,031.50 | 453,391.14 | 513,491.02 | 68,766.70 | -11,645.01 | 0.00 | |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Net Income | -56,997.10 | -121,244.40 | -44,079.12 | -64,506.05 | -4,542.65 | |
| Depreciation & Amortization | 57.50 | 1,384.73 | 13.16 | 12.36 | 0.00 | |
| Stock-Based Compensation | 6,536.61 | 7,281.60 | 7,106.01 | 9,654.78 | 0.00 | |
| Change Working Capital | -13,692.12 | -3,783.48 | -6,217.72 | -1,427.47 | 0.00 | |
| Change In Accounts Receivable | -1,057.05 | -1,786.34 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-cash Items | 3,875.16 | -225.71 | 399.51 | 372.49 | 3,931.58 | |
| Cash from Operations | -64,433.69 | 0.00 | -42,778.17 | -55,893.90 | -611.07 | |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Capital Expenditure | -496.40 | -519.52 | -284.63 | -16.01 | 0.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | -175,906,865.93 | -350,278.78 | -175,732.71 | -42,226.02 | 0.00 | |
| Sales of Investment | 176,328.24 | 145,203.00 | 150,833.02 | 9,901.44 | 0.00 | |
| Other Investing Activities | 175,528,211.39 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from Investing | -174,055.80 | 0.00 | -25,184.32 | -32,340.59 | 0.00 | |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | -15,000.00 | 0.00 | |
| Debt Issued | 3,132.77 | -976.56 | 3,523.54 | 282.58 | 15,000.00 | |
| Issuance of Common Stock | 83,709.52 | 0.00 | 482,454.43 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.05 | -0.05 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -4,315.15 | 0.00 | -2,752.92 | 134,692.74 | -58.06 | |
| Cash from Financing | 79,394.32 | 0.00 | 479,701.51 | 119,692.74 | -58.06 | |
| Cash position | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Net Change in Cash | -158,995.86 | -270,742.89 | 411.66 | 31,466.78 | -669.13 | |
| Closing Cash Balance | 342,791.14 | 180,426.45 | 451,169.34 | 39,505.63 | 666.79 | |
| Free Cash Flow | TTM | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Free Cash Flow | -64,930.09 | -117,106.78 | -43,062.80 | -55,909.91 | -611.07 | |
| Real Free Cash Flow | -71,466.70 | -124,388.38 | -50,168.81 | -65,564.69 | -611.07 | |
| Nacenění | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| P/E | -13.52 | -28.62 | -82.39 | -4.78 | -1.45 | -1,853.11 | |
| P/EG | -0.35 | -0.18 | 1.23 | 0.07 | 0.00 | 0.00 | |
| P/B | 8.44 | 7.62 | 5.98 | 6.30 | -6.66 | 1.50 | |
| P/S | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/FCF | -13.69 | -29.07 | -68.89 | -5.51 | -2.20 | -531.53 | |
| P/OFC | -13.69 | -29.20 | -69.35 | -5.52 | -2.20 | -531.53 | |
| Price/EV | -12.96 | -22.77 | -46.56 | -4.14 | -1.58 | -1,839.04 | |
| Marže | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| EBIT Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Operating Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Finanční zdraví | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Current Ratio | 16.65 | 21.11 | 51.59 | 9.98 | 0.46 | 12.93 | |
| Quick Ratio | 16.65 | 21.11 | 51.59 | 9.98 | 0.39 | 12.93 | |
| Solvency Ratio | -0.53 | -4.79 | -2.76 | -7.99 | -2.52 | 0.03 | |
| Cash Ratio | 11.21 | 8.03 | 45.27 | 5.15 | 0.38 | 10.67 | |
| Debt To Assets Ratio | 0.16 | 0.01 | 0.01 | 0.00 | 1.55 | 0.00 | |
| Debt To Equity Ratio | 0.21 | 0.01 | 0.01 | 0.01 | -1.29 | 0.00 | |
| Financial Leverage Ratio | 1.30 | 1.07 | 1.06 | 1.57 | -0.83 | 1.04 | |
| Debt Service Coverage Ratio | -14.85 | 0.00 | 0.00 | 0.00 | -3.58 | 1.99 | |
| Interest Coverage Ratio | -29.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Data na akcii | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income Per Share | -2.79 | -1.89 | -0.73 | -2.20 | -6.84 | -0.01 | |
| Cash Per Share | 6.72 | 7.13 | 10.40 | 2.46 | 1.03 | 0.09 | |
| Shareholders Equity Per Share | 5.59 | 7.11 | 10.09 | 1.67 | -1.49 | 7.60 | |
| Free Cash Flow Per Share | -2.64 | -1.86 | -0.88 | -1.90 | -4.49 | -0.02 | |
| Dividend Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Efektivita | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Effective Tax Rate | -0.2% | -0.2% | -0.2% | -0.1% | 0.0% | 227.1% | |
| Receivables Turnover | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Payables Turnover | 0.06 | 0.00 | 0.00 | 0.26 | 0.00 | 0.00 | |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Asset Turnover | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
